JP2021519597A5 - - Google Patents

Info

Publication number
JP2021519597A5
JP2021519597A5 JP2020554448A JP2020554448A JP2021519597A5 JP 2021519597 A5 JP2021519597 A5 JP 2021519597A5 JP 2020554448 A JP2020554448 A JP 2020554448A JP 2020554448 A JP2020554448 A JP 2020554448A JP 2021519597 A5 JP2021519597 A5 JP 2021519597A5
Authority
JP
Japan
Prior art keywords
rsv
polypeptide
antigenic
seq
polypeptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020554448A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519597A (ja
JP7614841B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025387 external-priority patent/WO2019195291A1/en
Publication of JP2021519597A publication Critical patent/JP2021519597A/ja
Publication of JP2021519597A5 publication Critical patent/JP2021519597A5/ja
Priority to JP2024153695A priority Critical patent/JP2024170566A/ja
Application granted granted Critical
Publication of JP7614841B2 publication Critical patent/JP7614841B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020554448A 2018-04-03 2019-04-02 抗原性呼吸器合胞体ウイルスポリペプチド Active JP7614841B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024153695A JP2024170566A (ja) 2018-04-03 2024-09-06 抗原性呼吸器合胞体ウイルスポリペプチド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862652199P 2018-04-03 2018-04-03
US62/652,199 2018-04-03
PCT/US2019/025387 WO2019195291A1 (en) 2018-04-03 2019-04-02 Antigenic respiratory syncytial virus polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024153695A Division JP2024170566A (ja) 2018-04-03 2024-09-06 抗原性呼吸器合胞体ウイルスポリペプチド

Publications (3)

Publication Number Publication Date
JP2021519597A JP2021519597A (ja) 2021-08-12
JP2021519597A5 true JP2021519597A5 (cg-RX-API-DMAC7.html) 2022-04-07
JP7614841B2 JP7614841B2 (ja) 2025-01-16

Family

ID=66182672

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020554448A Active JP7614841B2 (ja) 2018-04-03 2019-04-02 抗原性呼吸器合胞体ウイルスポリペプチド
JP2024153695A Pending JP2024170566A (ja) 2018-04-03 2024-09-06 抗原性呼吸器合胞体ウイルスポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024153695A Pending JP2024170566A (ja) 2018-04-03 2024-09-06 抗原性呼吸器合胞体ウイルスポリペプチド

Country Status (10)

Country Link
US (2) US12071454B2 (cg-RX-API-DMAC7.html)
EP (1) EP3773704A1 (cg-RX-API-DMAC7.html)
JP (2) JP7614841B2 (cg-RX-API-DMAC7.html)
KR (1) KR102964264B1 (cg-RX-API-DMAC7.html)
CN (1) CN112512567A (cg-RX-API-DMAC7.html)
AU (1) AU2019247034B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020019938A2 (cg-RX-API-DMAC7.html)
CA (1) CA3095175A1 (cg-RX-API-DMAC7.html)
MX (1) MX2020010199A (cg-RX-API-DMAC7.html)
WO (1) WO2019195291A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3773698A1 (en) 2018-04-03 2021-02-17 Sanofi Ferritin proteins
CN112512566A (zh) 2018-04-03 2021-03-16 赛诺菲 抗原性爱泼斯坦-巴尔病毒多肽
JP7614841B2 (ja) 2018-04-03 2025-01-16 サノフイ 抗原性呼吸器合胞体ウイルスポリペプチド
US20230302112A1 (en) 2021-11-05 2023-09-28 Sanofi Respiratory synctial virus rna vaccine
WO2023201222A1 (en) * 2022-04-11 2023-10-19 Vanderbilt University Ferritin nanoparticles and methods of use thereof
WO2024041772A1 (en) * 2022-08-22 2024-02-29 Glaxosmithkline Biologicals Sa Rsv-f proteins
WO2024078597A1 (en) * 2022-10-13 2024-04-18 Rvac Medicines (Us) , Inc. Rsv f protein variants and uses thereof
KR20250099727A (ko) 2022-11-04 2025-07-02 사노피 파스퇴르 인크 호흡기 세포융합 바이러스 rna 백신접종
US20250009865A1 (en) 2023-05-10 2025-01-09 Sanofi Combination respiratory mrna vaccines
CN122180699A (zh) * 2023-08-03 2026-06-09 广州宾和企业管理合伙企业(有限合伙) 修饰的呼吸道合胞病毒f蛋白及其用途
WO2025092933A1 (zh) * 2023-10-31 2025-05-08 上海蓝鹊生物医药有限公司 一种rsv抗原、核酸、重组表达载体、药物组合物及其应用
CN117586359A (zh) * 2024-01-19 2024-02-23 北京安百胜生物科技有限公司 一种具有免疫原性的呼吸道合胞病毒(rsv)多肽
CN120099235A (zh) * 2025-05-09 2025-06-06 北京华诺泰生物医药科技有限公司 一种微生物发酵工艺的优化方法及装置

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9407182A (pt) 1993-08-06 1996-09-17 Connaught Lab Composição imunogênica processo de preparo de composição não-imunopotencializadora imunogênica processo para determinar a presença de anticorpos estojo para diagnóstico para determinar a presença de anticorpos e virus sincicial respiratório humano inativado purificado
US5585250A (en) * 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
CA2281838A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP1003531B1 (en) 1997-05-20 2007-08-22 Ottawa Health Research Institute Processes for preparing nucleic acid constructs
US6218371B1 (en) 1998-04-03 2001-04-17 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
WO2001075436A1 (en) 2000-04-03 2001-10-11 Board Of Trustees Of The Leland Stanford Junior University A method for protein structure alignment
EP1311540B1 (en) 2000-08-18 2007-12-19 Research Foundation Of State University Of New York Altered ospa of borrelia burgdorferi
US7097841B2 (en) 2002-05-10 2006-08-29 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
US7774185B2 (en) 2004-09-14 2010-08-10 International Business Machines Corporation Protein structure alignment using cellular automata
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
US20100285051A1 (en) 2007-12-21 2010-11-11 Dominique Ingrid Lemoine Vaccine
US8563002B2 (en) 2007-12-24 2013-10-22 Glaxosmithkline Biologicals, S.A. Recombinant RSV antigens
US20110117131A1 (en) 2008-04-09 2011-05-19 Ning Huang Production of OspA for Lyme Disease Control
ES2987238T3 (es) 2008-12-09 2024-11-14 Novavax Inc Proteínas F del RSV modificadas y métodos de su uso
EP4183412B1 (en) 2009-07-15 2024-08-14 GlaxoSmithKline Biologicals SA Rsv f protein compositions and methods for making same
US8623375B2 (en) 2010-05-14 2014-01-07 Baxter International Inc. Chimeric OspA genes, proteins, and methods of use thereof
WO2012006180A1 (en) 2010-06-29 2012-01-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hiv immunogens
US20140186371A1 (en) 2011-04-07 2014-07-03 Guriqbal S. Basi Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
EP2515112B1 (en) 2011-04-22 2015-08-12 Sysmex Corporation Method for electrochemically detecting analyte
JP5795184B2 (ja) 2011-04-22 2015-10-14 国立大学法人 奈良先端科学技術大学院大学 被検物質の電気化学的検出方法
US20140348865A1 (en) 2011-09-12 2014-11-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Ser. Immunogens based on an hiv-1 v1v2 site-of-vulnerability
EP2758075B1 (en) * 2011-09-20 2023-05-03 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
WO2013044203A2 (en) 2011-09-23 2013-03-28 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPTARTMENT OF HEALTH & HUMAN SERVICES Novel influenza hemagglutinin protein-based vaccines
EP2877205A4 (en) 2012-07-26 2016-04-06 Jackson H M Found Military Med VACCINE WITH A MULTIMED FUSION PROTEIN AND IMMUNOTHERAPY
EP4421177A3 (en) 2013-03-13 2024-12-18 The United States of America, as represented by the Secretary, Department of Health and Human Services Prefusion rsv f proteins and their use
EP3054971B1 (en) 2013-10-11 2021-03-10 The United States of America, represented by the Secretary, Department of Health and Human Services Epstein-barr virus vaccines
CZ2014320A3 (cs) 2014-05-09 2015-11-18 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy
US10363301B2 (en) * 2014-05-27 2019-07-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Stabilized influenza hemagglutinin stem region trimers and uses thereof
US9703095B2 (en) 2015-01-05 2017-07-11 Edward Pakhchyan Light modulator for MEMS display
US10301377B2 (en) * 2015-02-24 2019-05-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
MX2018006785A (es) 2015-12-04 2018-11-09 Dana Farber Cancer Inst Inc Vacunacion con el dominio alfa 3 de mica/b para el tratamiento del cancer.
CN115960263A (zh) * 2016-03-29 2023-04-14 美国政府(由卫生和人类服务部的部长所代表) 取代修饰的融合前rsv f蛋白及其用途
CN109310749B (zh) 2016-06-07 2022-09-23 德国癌症研究中心 Hpv l2肽免疫原性的改善
KR102724939B1 (ko) 2016-06-17 2024-11-01 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 선형 또는 분지형 폴리아크릴산 폴리머 아쥬반트를 포함하는 신규한 면역원성 제형
EP3474893A1 (en) 2016-06-27 2019-05-01 The U.S.A. as represented by the Secretary, Department of Health and Human Services Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
EP3612562A2 (en) 2017-04-19 2020-02-26 Institute for Research in Biomedicine Plasmodium sporozoite npdp peptides as vaccine and target novel malaria vaccines and antibodies binding to
MA50813A (fr) 2017-11-21 2020-09-30 Modernatx Inc Vaccins contre le virus d'epstein-barr
CN112584858A (zh) 2018-04-03 2021-03-30 赛诺菲 抗原性ospa多肽
EP3773698A1 (en) 2018-04-03 2021-02-17 Sanofi Ferritin proteins
JP2021519600A (ja) 2018-04-03 2021-08-12 サノフイSanofi 抗原性インフルエンザ−フェリチンポリペプチド
CN112512566A (zh) 2018-04-03 2021-03-16 赛诺菲 抗原性爱泼斯坦-巴尔病毒多肽
JP7614841B2 (ja) 2018-04-03 2025-01-16 サノフイ 抗原性呼吸器合胞体ウイルスポリペプチド

Similar Documents

Publication Publication Date Title
AU2022279441B2 (en) Novel multivalent nanoparticle-based vaccines
JP6048845B2 (ja) ジフテリア毒素の無毒性突然変異体crm197又はその断片を含む融合タンパク質
JP2023162283A5 (cg-RX-API-DMAC7.html)
AU2022268296A1 (en) Vaccine against RSV
JP2021519596A5 (cg-RX-API-DMAC7.html)
JP2021519599A5 (cg-RX-API-DMAC7.html)
WO2023186170A1 (zh) 一种新冠病毒Delta和Omicron变异株嵌合抗原、其制备方法和应用
JP2012501959A5 (cg-RX-API-DMAC7.html)
CN111050795B (zh) 基于合成的多肽表位的疫苗组合物
JP2014507146A5 (cg-RX-API-DMAC7.html)
JP2012531219A (ja) Hivワクチン組成物における使用又は診断手段としての使用のためのhiv関連ペプチドの組合せ又は融合物
TW202130363A (zh) 變異型rsv f蛋白質及其利用
JP2016520534A5 (cg-RX-API-DMAC7.html)
TWI848947B (zh) 家塵蟎過敏的治療及預防
CN115124626A (zh) 串联式杂合三聚体新冠疫苗
JP4236215B2 (ja) 非型性のヘモフイルス インフルエンザ(Haemophilus influenzae)株用のワクチンとしての精製非型性ヘモフイルス インフルエンザP5蛋白質
WO2024047090A3 (en) Modified virus-like particles of cmv
CA2789432A1 (en) Serologic correlates of protection against bacillis anthracis infection
WO2012037779A1 (zh) 融合蛋白SAmB及其编码基因与应用
JP2023544300A5 (cg-RX-API-DMAC7.html)
Jang et al. Expression and immunogenic analysis of recombinant polypeptides derived from capsid protein VP1 for developing subunit vaccine material against hepatitis A virus
Qiu et al. Calreticulin as a hydrophilic chimeric molecular adjuvant enhances IgG responses to the spike protein of severe acute respiratory syndrome coronavirus
US9562080B2 (en) Lyme disease vaccine, genetic construct, recombinant protein, method for designing genetic construct, method for producing vaccine, method for producing recombinant proteins, use of recombinant proteins in the production of lyme disease vaccine
JP7219212B2 (ja) Mhc結合ペプチドアレイおよびその使用方法
RU2020135568A (ru) Антигенные полипептиды на основе последовательности респираторно-синцитиального вируса